Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1156

1.

111In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis.

Fujiwara K, Tsuji AB, Sudo H, Sugyo A, Akiba H, Iwanari H, Kusano-Arai O, Tsumoto K, Momose T, Hamakubo T, Higashi T.

Ann Nucl Med. 2019 Oct 12. doi: 10.1007/s12149-019-01408-y. [Epub ahead of print]

PMID:
31605356
2.

Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.

Ozaki A, Saito H, Onoue Y, Sawano T, Shimada Y, Somekawa Y, Tsuji A, Tanimoto T.

BMJ Open. 2019 Sep 6;9(9):e028805. doi: 10.1136/bmjopen-2018-028805.

3.

Identification and enzymatic characterization of clip domain serine protease in the digestive fluid of the sea hare, Aplysia kurodai.

Tsuji A, Yuasa K.

Comp Biochem Physiol B Biochem Mol Biol. 2019 Nov;237:110322. doi: 10.1016/j.cbpb.2019.110322. Epub 2019 Aug 24.

PMID:
31454681
4.

Comparison of ablation outcomes of the second ablation procedure for recurrent atrial fibrillation using an ultra-high-resolution mapping system and conventional mappings system.

Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Okuno S, Tsuji A, Mano T.

Clin Cardiol. 2019 Oct;42(10):966-973. doi: 10.1002/clc.23248. Epub 2019 Aug 12.

5.

Usefulness of an IKr blocker for ablation of non-pulmonary vein ectopies that are unmappable due to easily initiated atrial fibrillation.

Masuda M, Konishi S, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Okuno S, Tsuji A, Minamiguchi H, Mizuno H, Sakata Y, Mano T.

J Interv Card Electrophysiol. 2019 Jul 18. doi: 10.1007/s10840-019-00590-3. [Epub ahead of print]

PMID:
31321657
6.

A decapolar 25-mm-diameter circular mapping catheter with improved detection of pulmonary vein potential disappearance in cryoballoon ablation.

Matsuda Y, Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Tsuji A, Mano T.

J Arrhythm. 2019 May 14;35(3):535-541. doi: 10.1002/joa3.12192. eCollection 2019 Jun.

7.

Single incision laparoscopic surgery (SILS) for Meckel's diverticulum.

Kuramoto K, Nakahara O, Maeda Y, Kumamoto S, Tsuji A, Hayashida S, Oya Y, Shibata H, Iizaka M, Tomiyasu S, Hayashi H, Inomata Y, Baba H.

J Surg Case Rep. 2019 Jul 4;2019(7):rjz210. doi: 10.1093/jscr/rjz210. eCollection 2019 Jul.

8.

Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.

Yamada Y, Koizumi W, Nishikawa K, Gotoh M, Fuse N, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Hyodo I.

Cancer Sci. 2019 Sep;110(9):2875-2883. doi: 10.1111/cas.14117. Epub 2019 Jul 23.

9.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum.

Int J Clin Oncol. 2019 Jun 15. doi: 10.1007/s10147-019-01485-z. [Epub ahead of print]

PMID:
31203527
10.

The derivation of predictive equations to speculate the post-mortem interval using cases with over 20-mL pleural effusion: A preliminary study.

Usumoto Y, Kudo K, Tsuji A, Ihama Y, Ikeda N.

J Forensic Leg Med. 2019 Jul;65:61-67. doi: 10.1016/j.jflm.2019.05.001. Epub 2019 May 9.

PMID:
31103925
11.

Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER).

Moriwaki T, Sakai Y, Ishida H, Yamamoto Y, Endo S, Kuramochi H, Sato M, Hatachi Y, Bando Y, Maeba T, Ikezawa K, Shimada M, Amagai K, Morimoto M, Kobayashi K, Tsuji A, Nishina T, Hyodo I.

Int J Clin Oncol. 2019 Oct;24(10):1214-1222. doi: 10.1007/s10147-019-01465-3. Epub 2019 May 14.

PMID:
31089842
12.

Preclinical Evaluation of the Acute Radiotoxicity of the α-Emitting Molecular-Targeted Therapeutic Agent 211At-MABG for the Treatment of Malignant Pheochromocytoma in Normal Mice.

Sudo H, Tsuji AB, Sugyo A, Nagatsu K, Minegishi K, Ishioka NS, Ito H, Yoshinaga K, Higashi T.

Transl Oncol. 2019 Jul;12(7):879-888. doi: 10.1016/j.tranon.2019.04.008. Epub 2019 May 9.

13.

Radiation Dose Reduction at Pediatric CT: Use of Low Tube Voltage and Iterative Reconstruction-Erratum.

Nagayama Y, Oda S, Nakaura T, Tsuji A, Urata J, Furusawa M, Utsunomiya D, Funama Y, Kidoh M, Yamashita Y.

Radiographics. 2019 May-Jun;39(3):912. doi: 10.1148/rg.2019194005. No abstract available.

PMID:
31059408
14.

Comparison of electrogram waveforms between a multielectrode mapping catheter and a linear ablation catheter.

Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Okuno S, Tsuji A, Mano T.

Pacing Clin Electrophysiol. 2019 May;42(5):515-520. doi: 10.1111/pace.13644. Epub 2019 Mar 25.

PMID:
30882916
15.

Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately.

Yoshida T, Hijioka S, Hosoda W, Ueno M, Furukawa M, Kobayashi N, Ikeda M, Ito T, Kodama Y, Morizane C, Notohara K, Taguchi H, Kitano M, Yane K, Tsuchiya Y, Komoto I, Tanaka H, Tsuji A, Hashigo S, Mine T, Kanno A, Murohisa G, Miyabe K, Takagi T, Matayoshi N, Sakaguchi M, Ishii H, Kojima Y, Matsuo K, Yoshitomi H, Nakamori S, Yanagimoto H, Yatabe Y, Furuse J, Mizuno N.

Ann Surg Oncol. 2019 May;26(5):1385-1393. doi: 10.1245/s10434-019-07252-8. Epub 2019 Mar 12.

PMID:
30863939
16.

Impact of Renal Dysfunction on Left Atrial Low-Voltage Areas in Patients With Atrial Fibrillation.

Matsuda Y, Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Okuno S, Tsuji A, Mano T.

Circ J. 2019 Apr 25;83(5):985-990. doi: 10.1253/circj.CJ-18-1277. Epub 2019 Mar 9.

17.

64Cu-Intraperitoneal Radioimmunotherapy: A Novel Approach for Adjuvant Treatment in a Clinically Relevant Preclinical Model of Pancreatic Cancer.

Yoshii Y, Matsumoto H, Yoshimoto M, Oe Y, Zhang MR, Nagatsu K, Sugyo A, Tsuji AB, Higashi T.

J Nucl Med. 2019 Oct;60(10):1437-1443. doi: 10.2967/jnumed.118.225045. Epub 2019 Mar 8.

PMID:
30850497
18.

Defining the mechanism of action of S1QELs, specific suppressors of superoxide production in the quinone-reaction site in mitochondrial complex I.

Banba A, Tsuji A, Kimura H, Murai M, Miyoshi H.

J Biol Chem. 2019 Apr 19;294(16):6550-6561. doi: 10.1074/jbc.RA119.007687. Epub 2019 Mar 1.

PMID:
30824536
19.

Anti‑tissue factor antibody‑mediated immuno‑SPECT imaging of tissue factor expression in mouse models of pancreatic cancer.

Sugyo A, Aung W, Tsuji AB, Sudo H, Takashima H, Yasunaga M, Matsumura Y, Saga T, Higashi T.

Oncol Rep. 2019 Apr;41(4):2371-2378. doi: 10.3892/or.2019.7017. Epub 2019 Feb 14.

PMID:
30816521
20.

Therapeutic efficacy evaluation of radioimmunotherapy with 90 Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma.

Sudo H, Tsuji AB, Sugyo A, Saga T, Kaneko MK, Kato Y, Higashi T.

Cancer Sci. 2019 May;110(5):1653-1664. doi: 10.1111/cas.13979. Epub 2019 Mar 12.

21.

Roles of PI3K/AKT/GSK3 Pathway Involved in Psychiatric Illnesses.

Matsuda S, Ikeda Y, Murakami M, Nakagawa Y, Tsuji A, Kitagishi Y.

Diseases. 2019 Feb 13;7(1). pii: E22. doi: 10.3390/diseases7010022. Review.

22.

Predictive equation for post-mortem interval using spectrophotometric values of post-mortem lividity: A pilot study.

Usumoto Y, Kudo K, Tsuji A, Ihama Y, Ikeda N.

Forensic Sci Int. 2019 Apr;297:47-55. doi: 10.1016/j.forsciint.2019.01.014. Epub 2019 Jan 19.

PMID:
30772770
23.

Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer.

Mishima S, Kawazoe A, Nakamura Y, Sasaki A, Kotani D, Kuboki Y, Bando H, Kojima T, Doi T, Ohtsu A, Yoshino T, Kuwata T, Tsuji A, Shitara K.

J Immunother Cancer. 2019 Jan 31;7(1):24. doi: 10.1186/s40425-019-0514-3.

24.

Efficacy of metformin on postprandial plasma triglyceride concentration by administration timing in patients with type 2 diabetes mellitus: A randomized cross-over pilot study.

Sato D, Morino K, Ogaku S, Tsuji A, Nishimura K, Sekine O, Ugi S, Maegawa H.

J Diabetes Investig. 2019 Sep;10(5):1284-1290. doi: 10.1111/jdi.13016. Epub 2019 Feb 22.

25.

[Significance of monitoring cerebrospinal fluid leukocyte counts in managing central nervous system disease of acute myeloid leukemia in patients presenting with intracerebral hemorrhage upon initial examination].

Kawahara M, Teramoto Y, Asai A, Nagai S, Iwasa M, Fujishiro A, Nishimura R, Minamiguchi H, Tsuji A, Kito K, Andoh A.

Rinsho Ketsueki. 2018;59(12):2578-2582. doi: 10.11406/rinketsu.59.2578. Japanese.

PMID:
30626792
26.

Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.

Aung W, Tsuji AB, Sugyo A, Takashima H, Yasunaga M, Matsumura Y, Higashi T.

World J Gastroenterol. 2018 Dec 28;24(48):5491-5504. doi: 10.3748/wjg.v24.i48.5491.

27.

Predictive equation to estimate post-mortem interval using spectrophotometric blood-colour values.

Usumoto Y, Kudo K, Tsuji A, Ihama Y, Ikeda N.

Med Sci Law. 2019 Jan;59(1):36-41. doi: 10.1177/0025802418819611. Epub 2019 Jan 8.

PMID:
30621492
28.

Effects of quadriceps muscle neuromuscular electrical stimulation in living donor liver transplant recipients: phase-II single-blinded randomized controlled trial.

Hanada M, Soyama A, Hidaka M, Nagura H, Oikawa M, Tsuji A, Kasawara KT, Mathur S, Reid WD, Takatsuki M, Eguchi S, Kozu R.

Clin Rehabil. 2019 May;33(5):875-884. doi: 10.1177/0269215518821718. Epub 2019 Jan 4.

PMID:
30607983
29.

A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2).

Kato K, Satoh T, Muro K, Yoshikawa T, Tamura T, Hamamoto Y, Chin K, Minashi K, Tsuda M, Yamaguchi K, Machida N, Esaki T, Goto M, Komatsu Y, Nakajima TE, Sugimoto N, Yoshida K, Oki E, Nishina T, Tsuji A, Fujii H, Kunieda K, Saitoh S, Omuro Y, Azuma M, Iwamoto Y, Taku K, Fushida S, Chen LT, Kang YK, Boku N.

Gastric Cancer. 2019 Mar;22(2):344-354. doi: 10.1007/s10120-018-0899-6. Epub 2018 Dec 1.

30.

Inhibition of autophagy by chloroquine makes chemotherapy in nasopharyngeal carcinoma more efficient.

Aga T, Endo K, Tsuji A, Aga M, Moriyama-Kita M, Ueno T, Nakanishi Y, Hatano M, Kondo S, Sugimoto H, Wakisaka N, Yoshizaki T.

Auris Nasus Larynx. 2019 Jun;46(3):443-450. doi: 10.1016/j.anl.2018.10.013. Epub 2018 Dec 2.

PMID:
30514592
31.

Prolonged QRS duration as a predictor of right ventricular dysfunction after balloon pulmonary angioplasty.

Asano R, Ogo T, Ohta-Ogo K, Fukui S, Tsuji A, Ueda J, Konagai N, Fukuda T, Morita Y, Noguchi T, Kusano K, Anzai T, Ishibashi-Ueda H, Yasuda S.

Int J Cardiol. 2019 Apr 1;280:176-181. doi: 10.1016/j.ijcard.2018.11.026. Epub 2018 Nov 10.

PMID:
30448112
32.

aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer.

Fujita Y, Taguri M, Yamazaki K, Tsurutani J, Sakai K, Tsushima T, Nagase M, Tamagawa H, Ueda S, Tamura T, Tsuji Y, Murata K, Taira K, Denda T, Moriwaki T, Funai S, Nakajima TE, Muro K, Tsuji A, Yoshida M, Suyama K, Kurimoto T, Sugimoto N, Baba E, Seki N, Sato M, Shimura T, Boku N, Hyodo I, Yamanaka T, Nishio K.

Oncologist. 2019 Mar;24(3):327-337. doi: 10.1634/theoncologist.2018-0119. Epub 2018 Nov 13.

PMID:
30425180
33.
34.

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design.

Moehler M, Ryu MH, Dvorkin M, Lee KW, Coşkun HŞ, Wong R, Chung HC, Poltoratsky A, Tsuji A, Yen CJ, Muntean AS, Le Sourd S, Vaccaro GM, Overton L, Boku N, Wainberg ZA, Patel M, Sharma M, Xiong H, Conti I, Taieb J, Bang YJ.

Future Oncol. 2019 Feb;15(6):567-577. doi: 10.2217/fon-2018-0668. Epub 2018 Oct 31.

35.

Direct comparison of 2‑amino[3‑11C]isobutyric acid and 2‑amino[11C]methyl‑isobutyric acid uptake in eight lung cancer xenograft models.

Sudo H, Tsuji AB, Sugyo A, Okada M, Kato K, Zhang MR, Saga T, Higashi T.

Int J Oncol. 2018 Dec;53(6):2737-2744. doi: 10.3892/ijo.2018.4596. Epub 2018 Oct 16.

PMID:
30334568
36.

A phase II study of NK012, a polymeric micelle formulation of SN-38, in unresectable, metastatic or recurrent colorectal cancer patients.

Hamaguchi T, Tsuji A, Yamaguchi K, Takeda K, Uetake H, Esaki T, Amagai K, Sakai D, Baba H, Kimura M, Matsumura Y, Tsukamoto T.

Cancer Chemother Pharmacol. 2018 Dec;82(6):1021-1029. doi: 10.1007/s00280-018-3693-6. Epub 2018 Oct 4.

37.

Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer.

Sunakawa Y, Mogushi K, Lenz HJ, Zhang W, Tsuji A, Takahashi T, Denda T, Shimada K, Kochi M, Nakamura M, Kotaka M, Segawa Y, Tanioka H, Negoro Y, Moran M, Astrow SH, Hsiang J, Stephens C, Fujii M, Ichikawa W.

Mol Cancer Ther. 2018 Dec;17(12):2788-2795. doi: 10.1158/1535-7163.MCT-18-0694. Epub 2018 Oct 1.

PMID:
30275242
38.

Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer.

Sugyo A, Tsuji AB, Sudo H, Koizumi M, Ukai Y, Kurosawa G, Kurosawa Y, Saga T, Higashi T.

Int J Mol Sci. 2018 Sep 29;19(10). pii: E2979. doi: 10.3390/ijms19102979.

39.

C-reactive Protein Level on Postoperative Day One is Associated with Chronic Postsurgical Pain After Mastectomy.

Hashimoto K, Tsuji A, Takenaka S, Ohmura A, Ueki R, Noma H, Imamura M, Miyoshi Y, Kariya N, Tatara T, Hirose M.

Anesth Pain Med. 2018 Aug 7;8(4):e79331. doi: 10.5812/aapm.79331. eCollection 2018 Aug.

40.

Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer.

Sunakawa Y, Yang D, Cao S, Zhang W, Moran M, Astrow SH, Hsiang J, Stephens C, Tsuji A, Takahashi T, Tanioka H, Negoro Y, Takagane A, Tani S, Yamaguchi T, Eto T, Fujii M, Ichikawa W, Lenz HJ.

Clin Colorectal Cancer. 2018 Dec;17(4):e741-e749. doi: 10.1016/j.clcc.2018.08.002. Epub 2018 Aug 23.

PMID:
30219280
41.

Development of Pulmonary Arterial Hypertension in a Patient Treated with Qing-Dai (Chinese Herbal Medicine).

Misumi K, Ogo T, Ueda J, Tsuji A, Fukui S, Konagai N, Asano R, Yasuda S.

Intern Med. 2019 Feb 1;58(3):395-399. doi: 10.2169/internalmedicine.1523-18. Epub 2018 Sep 12.

42.

Radiation Dose Reduction at Pediatric CT: Use of Low Tube Voltage and Iterative Reconstruction.

Nagayama Y, Oda S, Nakaura T, Tsuji A, Urata J, Furusawa M, Utsunomiya D, Funama Y, Kidoh M, Yamashita Y.

Radiographics. 2018 Sep-Oct;38(5):1421-1440. doi: 10.1148/rg.2018180041. Review. Erratum in: Radiographics. 2019 May-Jun;39(3):912.

PMID:
30207943
43.

Evaluation of health-related quality of life via the Computer-Based Health Evaluation System (CHES) for Japanese metastatic breast cancer patients: a single-center pilot study.

Kikawa Y, Hatachi Y, Rumpold G, Tokiwa M, Takebe S, Ogata T, Satake H, Kato H, Tsuji A, Yasui H, Holzner B.

Breast Cancer. 2019 Mar;26(2):255-259. doi: 10.1007/s12282-018-0905-1. Epub 2018 Sep 7.

44.

Citrus peel polymethoxyflavones, sudachitin and nobiletin, induce distinct cellular responses in human keratinocyte HaCaT cells.

Abe S, Hirose S, Nishitani M, Yoshida I, Tsukayama M, Tsuji A, Yuasa K.

Biosci Biotechnol Biochem. 2018 Dec;82(12):2064-2071. doi: 10.1080/09168451.2018.1514246. Epub 2018 Sep 5.

PMID:
30185129
45.

Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.

Yoshino T, Yamazaki K, Shinozaki E, Komatsu Y, Nishina T, Baba H, Tsuji A, Tsuji Y, Yamaguchi K, Sugimoto N, Denda T, Muro K, Takayama T, Esaki T, Hamamoto Y, Moriwaki T, Shimada Y, Goto M, Nakayama N, Fujii H, Tanase T, Ohtsu A.

Clin Colorectal Cancer. 2018 Dec;17(4):e719-e732. doi: 10.1016/j.clcc.2018.07.009. Epub 2018 Jul 26.

46.

Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane.

Satake H, Sagawa T, Fujikawa K, Hatachi Y, Yasui H, Kotaka M, Kato T, Tsuji A.

Cancer Chemother Pharmacol. 2018 Nov;82(5):839-845. doi: 10.1007/s00280-018-3678-5. Epub 2018 Aug 30.

47.

By using either endogenous or transplanted stem cells, which could you prefer for neural regeneration?

Matsuda S, Nakagawa Y, Amano K, Ikeda Y, Tsuji A, Kitagishi Y.

Neural Regen Res. 2018 Oct;13(10):1731-1732. doi: 10.4103/1673-5374.238609. No abstract available.

48.

Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study.

Li J, Xu R, Qin S, Liu T, Pan H, Xu J, Bi F, Lim R, Zhang S, Ba Y, Bai Y, Fan N, Tsuji A, Yeh KH, Ma B, Wei V, Shi D, Magherini E, Shen L.

Future Oncol. 2018 Aug;14(20):2031-2044. doi: 10.2217/fon-2017-0669. Epub 2018 Aug 17. Erratum in: Future Oncol. 2019 Feb;15(4):451.

49.

Robust Domination of Lactobacillus sakei in Microbiota During Traditional Japanese Sake Starter Yamahai-Moto Fermentation and the Accompanying Changes in Metabolites.

Tsuji A, Kozawa M, Tokuda K, Enomoto T, Koyanagi T.

Curr Microbiol. 2018 Nov;75(11):1498-1505. doi: 10.1007/s00284-018-1551-8. Epub 2018 Aug 16.

PMID:
30116836
50.

Centrifugal Wave Front Propagation Speed for Localizing the Origin of Ventricular Arrhythmias: Investigation Using a New Ultra-High-Resolution Mapping System.

Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Okuno S, Ohashi T, Tsuji A, Mano T.

JACC Clin Electrophysiol. 2018 Mar;4(3):355-363. doi: 10.1016/j.jacep.2017.11.002. Epub 2017 Dec 20.

Supplemental Content

Support Center